.Merck trumps incomes requirements, brings up sales overview on tough requirement for best medications like Keytruda CNBCMerck & Co. (MRK United States) Defeats Earnings Forecasts as Keytruda Sales Surge BloombergMerck Stock: Pharma Titan Posts Tough Results, However Expectation Falls Short Financier's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats income and also purchases desires amid Keytruda strength, but provides combined full-year outlook MarketWatch.